Emeritus Professor Michael Pender
Emeritus Professor
Royal Brisbane Clinical Unit
Researcher biography
Emeritus Professor Michael Pender graduated from The University of Queensland in 1974 with First Class Honours in Medicine and a University Medal. Over the next six years he trained as a physician and neurologist at the Royal Prince Alfred Hospital and St Vincent's Hospital, Sydney, and became a Fellow of the Royal Australasian College of Physicians (FRACP) in 1981. During his specialist clinical training he developed a keen interest in multiple sclerosis which he has continued since then. After completing his clinical training in neurology, he was a research scholar in the field of multiple sclerosis at the Institute of Neurology, Queen Square, London, and was awarded a PhD from the University of London and Queen Square Prize for Research in 1983. From 1984 to 1986 he continued this research as a Research Fellow at the John Curtin School of Medical Research, Australian National University, Canberra. In 1987 he was appointed Senior Lecturer in the Department of Medicine, The University of Queensland, at the Royal Brisbane Hospital. In 1989 he was awarded a Doctorate of Medicine from The University of Queensland for his research in the field of multiple sclerosis and was promoted to Reader in Medicine. In 1995 he was promoted to Professor of Medicine (Personal Chair), The University of Queensland, which he held until his retirement in 2021. His main clinical and research interest is multiple sclerosis. He also held the positions of: Consultant Neurologist, Royal Brisbane and Women's Hospital, 1987–2021; Director of Neurology, Royal Brisbane and Women's Hospital, 1992–2005: Director of the Neuroimmunology Research Centre, The University of Queensland, 1991–2007; Director of the Multiple Sclerosis Research Centre, The University of Queensland, 2009–2014; and Clinical Fellow, QIMR Berghofer Medical Research Institute, 2017–2021. In 1996, with the support of the Multiple Sclerosis Society of Queensland, he established a Multiple Sclerosis Clinic at the Royal Brisbane and Women's Hospital. In 2006 he was awarded the Multiple Sclerosis Australia Prize for Multiple Sclerosis Research - "For outstanding commitment and dedication to research into the cause and cure of Multiple Sclerosis in Australia". In 2011 he received the John H Tyrer Prize in Internal Medicine, The University of Queensland, for research in the field of Internal Medicine. He was the Sir Raphael Cilento Orator of the Royal Australasian College of Medical Administrators for 2009 and the W Ian McDonald Lecturer of the Australian and New Zealand Association of Neurologists for 2014. In 2019 he received the John Studdy Award from Multiple Sclerosis Australia for "lifelong commitment and service to research to identify the cause of and potential cure for Multiple Sclerosis". Major research achievements include: the discovery of apoptosis of autoreactive T cells in the central nervous system as a fundamental mechanism of recovery from autoimmune attack (Journal of the Neurological Sciences 1991, Journal of Autoimmunity 1992, European Journal of Immunology 1994); formulation of a novel hypothesis (The Lancet 1998) proposing a failure of this mechanism in multiple sclerosis; and the further development of this hypothesis into a new paradigm (Trends in Immunology 2003) for the cause of human chronic autoimmune diseases based on infection of autoreactive B cells with the Epstein–Barr virus (EBV), some of the predictions of which have already been verified in multiple sclerosis, rheumatoid arthritis and Sjögren’s syndrome. His EBV hypothesis led to the first clinical trial of EBV-specific T cell therapy in multiple sclerosis (JCI Insight 2018), a trial in which he was a principal investigator.
Group page: https://medicine-program.uq.edu.au/multiple-sclerosis-research-group
Book
Pender, Michael P. and McCombe, Pamela A. Autoimmune neurological disease. Cambridge, United Kingdom: Cambridge University Press, 2009. doi:10.1017/cbo9780511526916
Book Chapters
Pender, Michael P. (2004). Epstein-Barr Virus and Autoimmunity. Infection and Autoimmunity. (pp. 163-170) edited by Shoenfeld, Yehuda and Rose, Noel R.. Amsterdam: Elsevier. doi: 10.1016/B978-044451271-0.50013-2
Pender, Michael P. (1996). Immunopathology and Pathophysiology of Experimental Autoimmune Encephalomyelitis. The Neurobiology of Disease: Contributions from Neuroscience to Clinical Neurology. (pp. 75-85) edited by Bostock, H., Kirkwood, P. A. and Pullen, A. H.. Cambridge, UK: Cambridge University Press.
Pender, Michael P. (1995). Experimental Autoimmune Encephalomyelitis. Autoimmune Neurological Disease. (pp. 26-88) edited by Pender, Michael P. and McCombe, Pamela A.. Cambridge, UK: Cambridge University Press.
Pender, Michael P. (1995). The Stiff-Man Syndrome. Autoimmune Neurological Disease. (pp. 166-176) edited by Pender, Michael P. and McCombe, Pamela A.. Cambridge, UK: Cambridge University Press.
Pender, Michael P. (1995). Paraneoplastic Neurological Disorders. Autoimmune Neurological Disease. (pp. 327-344) edited by Pender, Michael P. and McCombe, Pamela A.. Cambridge, UK: Cambridge University Press.
Pender, Michael P. (1995). Acute Disseminated Encephalomyelitis. Autoimmune Neurological Disease. (pp. 155-165) edited by Pender, Michael P. and McCombe, Pamela A.. Cambridge, UK: Cambridge University Press.
Pender, Michael P. (1995). An Introduction to Neuroimmunology. Autoimmune Neurological Disease. (pp. 14-25) edited by Pender, Michael P. and McCombe, Pamela A.. Cambridge, UK: Cambridge University Press.
Pender, Michael P. (1995). Multiple Sclerosis. Autoimmune Neurological Disease. (pp. 89-154) edited by Pender, Michael P. and McCombe, Pamela A.. Cambridge, UK: Cambridge University Press.
Journal Articles
Saul, Alice M., Taylor, Bruce V., Blizzard, Leigh, Simpson-Yap, Steve, Oddy, Wendy H., Shivappa, Nittin, Hébert, James R., Black, Lucinda J., Ponsonby, Anne-Louise, Broadley, Simon A., Lechner-Scott, Jeanette, van der Mei, Ingrid, Lucas, Robyn M, Dear, Keith, Dwyer, Terry, Broadley, Simon, Kilpatrick, Trevor, Williams, David, Shaw, Cameron, Chapman, Caron, Coulthard, Alan, Pender, Michael P. and Valery, Patricia (2023). A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study. Multiple Sclerosis Journal, 29 (8), 1012-1023. doi: 10.1177/13524585231167739
Zarghami, Amin, van der Mei, Ingrid, Hussain, Mohammad Akhtar, Claflin, Suzi B, Bessing, Barnabas, Simpson-Yap, Steve, Ponsonby, Anne-Louise, Lechner-Scott, Jeanette, Broadley, Simon, Lucas, Robyn, Dear, Keith, Dwyer, Terry, Taylor, Bruce V, Kilpatrick, Trevor, Williams, David, Shaw, Cameron, Chapman, Caron, Coulthard, Alan, Pender, Michael P., Valery, Patricia and AusLong Investigator Group (2022). Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination. Multiple Sclerosis Journal, 28 (11), 1793-1807. doi: 10.1177/13524585221089900
Chapman, Caron, Lucas, Robyn M., Ponsonby, Anne-Louise, Taylor, Bruce, Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor, Lucas, Robyn, McMichael, Tony, Pender, Michael, Ponsonby, Anne-Louise, Valery, Patricia C., Van Der Mei, Ingrid and Williams, David (2022). Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis. Brain Communications, 4 (4) fcac181, 1-1155. doi: 10.1093/braincomms/fcac181
Bukhari, Wajih, Khalilidehkordi, Elham, Mason, Deborah F., Barnett, Michael H., Taylor, Bruce V., Fabis-Pedrini, Marzena, Kermode, Allan G., Subramanian, Sankar, Waters, Patrick, Broadley, Simon A., Bukhari, Wajih, Broadley, Simon A., Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brilot, Fabienne, Brownlee, Wallace J., Bundell, Christine S., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Clarke, Laura, Coulthard, Alan, Dale, Russell C., Das, Chandi, Dear, Keith ... Yiu, Eppie M. (2021). NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand. Journal of Neurology, 269 (2), 836-845. doi: 10.1007/s00415-021-10665-9
Simpson-Yap, Steve, Oddy, Wendy H, Taylor, Bruce, Lucas, Robyn M, Black, Lucinda J, Ponsonby, Anne-Louise, Blizzard, Leigh, van der Mei, Ingrid, Dear, Keith, Dwyer, Terry, Taylor, Bruce V., Broadley, Simon, Kilpatrick, Trevor, Williams, David, Lechner-Scott, Jeanette, Shaw, Cameron, Chapman, Caron, Coulthard, Alan, Pender, Michael P. and Valery, Patricia (2021). High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis. Multiple Sclerosis Journal, 27 (7), 1112-1124. doi: 10.1177/1352458520943087
Bar-Or, Amit, Pender, Michael P., Khanna, Rajiv, Steinman, Lawrence, Hartung, Hans-Peter, Maniar, Tap, Croze, Ed, Aftab, Blake T., Giovannoni, Gavin and Joshi, Manher A. (2021). Erratum: Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020) (Trends in Molecular Medicine (2020) 26(3) (296–310), (S1471491419302941), (10.1016/j.molmed.2019.11.003)). Trends in Molecular Medicine, 27 (4), 410-411. doi: 10.1016/j.molmed.2021.01.004
Ioannides, Zara A., Csurhes, Peter A., Douglas, Nanette L., Mackenroth, Gem, Swayne, Andrew, Thompson, Kate M., Hopkins, Tracey J., Green, Kerryn A., Blum, Stefan, Hooper, Kaye D., Wyssusek, Kerstin H., Coulthard, Alan and Pender, Michael P. (2021). Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy. Frontiers in Neurology, 12 652811, 652811. doi: 10.3389/fneur.2021.652811
Ioannides, Zara A., Csurhes, Peter A., Swayne, Andrew, Foubert, Philippe, Aftab, Blake T. and Pender, Michael P. (2021). Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis. Multiple Sclerosis Journal Experimental, Translational and Clinical, 7 (2), 1-12. doi: 10.1177/20552173211019772
Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2020). Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI insight, 5 (20) e144624. doi: 10.1172/jci.insight.144624
Greer, Judith M., Trifilieff, Elisabeth and Pender, Michael P. (2020). Correlation between anti-myelin proteolipid protein (PLP) antibodies and disease severity in multiple sclerosis patients with PLP response-permissive HLA types. Frontiers in Immunology, 11 1891, 1891. doi: 10.3389/fimmu.2020.01891
Yan, Jun, McCombe, Pamela A., Pender, Michael P. and Greer, Judith M. (2020). Reduced IκB-α protein levels in peripheral blood cells of patients with multiple sclerosis — a possible cause of constitutive NF-κB activation. Journal of Clinical Medicine, 9 (8) 2534, 2534-13. doi: 10.3390/jcm9082534
Pender, Michael P. (2020). Hypothesis: bipolar disorder is an Epstein-Barr virus-driven chronic autoimmune disease - implications for immunotherapy. Clinical & Translational Immunology, 9 (4) e1116, 1-12. doi: 10.1002/cti2.1116
Bar-Or, Amit, Pender, Michael P., Khanna, Rajiv, Steinman, Lawrence, Hartung, Hans-Peter, Maniar, Tap, Croze, Ed, Aftab, Blake T., Giovannoni, Gavin and Joshi, Manher J. (2019). Epstein–Barr virus in multiple sclerosis: theory and emerging immunotherapies. Trends in Molecular Medicine, 26 (3), 296-310. doi: 10.1016/j.molmed.2019.11.003
Ahmad, Hasnat, van der Mei, Ingrid, Taylor, Bruce, Lucas, Robyn M., Ponsonby, Anne-Louise, Lechner-Scott, Jeannette, Dear, Keith, Valery, Patricia, Clarke, Philip M., Simpson, Steve, Palmer, Andrew J., The Ausimmune and AusLong Investigator Groups, Dwyer, Terry, Blizzard, Leigh, Broadley, Simon, Kilpatrick, Trevor, Williams, David, Lechner-Scott, Jeanette, Shaw, Cameron, Chapman, Caron, Coulthard, Alan and Pender, Michael P. (2019). Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 25 (13), 1800-1808. doi: 10.1177/1352458518806103
Black, Lucinda J., Baker, Kimberley, Ponsonby, Anne-Louise, Van Der Mei, Ingrid, Lucas, Robyn M., Pereira, Gavin, Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor, McMichael Dec, Tony, Pender, Michael P., Taylor, Bruce, Valery, Patricia and Williams, David (2019). A higher mediterranean diet score, including unprocessed red meat, is associated with reduced risk of central nervous system demyelination in a case-control study of Australian adults. Journal of Nutrition, 149 (8), 1385-1392. doi: 10.1093/jn/nxz089
Black, Lucinda J., Bowe, Gabrielle S., Pereira, Gavin, Lucas, Robyn M., Dear, Keith, van der Mei, Ingrid, Sherriff, Jill L., and the Ausimmune Investigator Group, Chapman, Caron, Coulthard, Alan, Dwyer, Terry, Kilpatrick, Trevor, Lucas, Robyn, McMichael, Tony, Pender, Michael P., Ponsonby, Anne-Louise, Taylor, Bruce, Valery, Patricia and Williams, David (2019). Higher Non-processed Red Meat Consumption Is Associated With a Reduced Risk of Central Nervous System Demyelination. Frontiers in Neurology, 10 (FEB) 125. doi: 10.3389/fneur.2019.00125
Black, Lucinda J., Zhao, Yun, Peng, Yee Cheng, Sherriff, Jill L., Lucas, Robyn M., van der Mei, Ingrid, Ausimmune Investigator Group , Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor, Lucas, Robyn, McMichael, Tony, Pender, Michael P., Ponsonby, Anne-Louise, Taylor, Bruce, Valery, Patricia, van der Mei, Ingrid, Williams, David and Pereira, Gavin (2019). Higher fish consumption and lower risk of central nervous system demyelination. European Journal of Clinical Nutrition, 74 (5), 818-824. doi: 10.1038/s41430-019-0476-z
Pender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight, 3 (22) e124714. doi: 10.1172/jci.insight.124714
Cloake, Nancy, Yan, Jun, Aminian, Atefeh, Pender, Michael and Greer, Judith (2018). PLP1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutations. Journal of Clinical Medicine, 7 (10) 342, 342. doi: 10.3390/jcm7100342
Yan, Jun, Winterford, Clay M., Catts, Vibeke S., Pat, Betty K., Pender, Michael P., McCombe, Pamela A. and Greer, Judith M. (2018). Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis. Journal of Neuroimmunology, 320, 111-116. doi: 10.1016/j.jneuroim.2018.04.002
Tao, Chunrong, Simpson, Steve, Taylor, Bruce V., Blizzard, Leigh, Lucas, Robyn M., Ponsonby, Anne-Louise, Broadley, Simon, van der Mei, Ingrid, AusLong/Ausimmune Investigators Group, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor, Williams, David, Lechner-Scott, Jeanette, Shaw, Cameron, Chapman, Caron, Coulthard, Alan, Pender, Michael P. and Valery, Patricia (2018). Onset symptoms, tobacco smoking, and progressive-onset phenotype are associated with a delayed onset of multiple sclerosis, and marijuana use with an earlier onset. Frontiers in Neurology, 9 (JUN) 418. doi: 10.3389/fneur.2018.00418
Russell, Rebecca D., Lucas, Robyn M., Brennan, Vanessa, Sherriff, Jill L., Begley, Andrea, Black, Lucinda J., The Ausimmune Investigator Group, Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor, Lucas, Robyn, McMichael, Tony, Pender, Michael P., Ponsonby, Anne-Louise, Taylor, Bruce, Valery, Patricia, van der Mei, Ingrid and Williams, David (2018). Reported changes in dietary behavior following a first clinical diagnosis of central nervous system demyelination. Frontiers in Neurology, 9 (MAR) 161. doi: 10.3389/fneur.2018.00161
Simpson, Steve, Van Der Mei, Ingrid, Lucas, Robyn M., Ponsonby, Anne-Louise, Broadley, Simon, Blizzard, Leigh, Taylor, Bruce, Dear, Keith, Dwyer, Terry, Taylor, Bruce V., Kilpatrick, Trevor, Williams, David, Lechner-Scott, Jeanette, Shaw, Cameron, Chapman, Caron, Coulthard, Alan, Pender, Michael P. and Valery, Patricia (2018). Sun exposure across the life course significantly modulates early multiple sclerosis clinical course. Frontiers in Neurology, 9 (FEB) 16. doi: 10.3389/fneur.2018.00016
Bukhari, Wajih, Prain, Kerri M., Waters, Patrick, Woodhall, Mark, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Dale, Russell C., Das, Chandi, Dear, Keith, Fabis-Pedrini, Marzena J., Fulcher, David, Gillis, David, Hawke, Simon, Heard, Robert, Henderson, Andrew P. D. ... Broadley, Simon A. (2017). Incidence and prevalence of NMOSD in Australia and New Zealand. Journal of Neurology Neurosurgery and Psychiatry, 88 (8), 632-638. doi: 10.1136/jnnp-2016-314839
Saul, Alice, Ponsonby, Anne-Louise, Lucas, Robyn M., Taylor, Bruce V., Simpson, Steve, Jr., Valery, Patricia, Dwyer, Terence, Kilpatrick, Trevor J., Pender, Michael P. and van der Mei, Ingrid A. F. (2017). Stressful life events and the risk of initial central nervous system demyelination. Multiple Sclerosis Journal, 23 (7), 1000-1007. doi: 10.1177/1352458516667566
Greer, Judith M., Broadley, Simon and Pender, Michael P. (2017). Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid disease. Frontiers in Immunology, 8 (514) 514, 514. doi: 10.3389/fimmu.2017.00514
Pender, Michael P., Csurhes, Peter A., Burrows, Jacqueline M. and Burrows, Scott R. (2017). Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clinical and Translational Immunology, 6 (1) e126, 1-17. doi: 10.1038/cti.2016.87
Van Der Mei, I. A. F., Lucas, R. M., Taylor, B. V., Valery, P. C., Dwyer, T., Kilpatrick, T. J., Pender, M. P., Williams, D., Chapman, C., Otahal, P. and Ponsonby, A. L. (2016). Population attributable fractions and joint effects of key risk factors for multiple sclerosis. Multiple Sclerosis, 22 (4), 461-469. doi: 10.1177/1352458515594040
Pender, Michael P. and Burrows, Scott R. (2014). Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clinical and Translational Immunology, 3 (10) e27, e27. doi: 10.1038/cti.2014.25
Jones, Amanda L., Mowry, Bryan J., McLean, Duncan E., Mantzioris, Basil X., Pender, Michael P. and Greer, Judith M. (2014). Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia. Journal of Neuroimmunology, 269 (1-2), 68-75. doi: 10.1016/j.jneuroim.2014.02.008
Pender, Michael P., Csurhes, Peter A., Smith, Corey, Beagley, Leone, Hooper, Kaye D., Raj, Meenakshi, Coulthard, Alan, Burrows, Scott R. and Khanna, Rajiv (2014). Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. Multiple Sclerosis Journal, 20 (11), 1541-1544. doi: 10.1177/1352458514521888
Pender, Michael P., Csurhes, Peter A., Pfluger, Casey M. M. and Burrows, Scott R. (2014). Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis. Multiple Sclerosis Journal, 20 (14), 1825-1832. doi: 10.1177/1352458514536252
Pender, Michael P. and Khanna, Rajiv (2014). Epstein-Barr virus-specific adoptive immunotherapy: A new horizon for multiple sclerosis treatment?. Immunotherapy, 6 (6), 659-661. doi: 10.2217/imt.14.43
Guo, Shuyu, Lucas, Robyn M., Ponsonby, Anne-Louise, The Ausimmune Investigator Group, Coulthard, Alan and Pender, Michael P. (2013). A novel approach for prediction of vitamin D status using support vector regression. PLoS ONE, 8 (11) e79970, e79970.1-e79970.9. doi: 10.1371/journal.pone.0079970
Ponsonby, Anne-Louise, Lucas, Robyn M., Dear, Keith, van der Mei, Ingrid, Taylor, Bruce, Chapman, Caron, Coulthard, Alan, Dwyer, Terence, Kilpatrick, Trevor J., McMichael, Anthony J., Pender, Michael P., Valery, Patricia C. and Williams, David (2013). The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: the Ausimmune study. Multiple Sclerosis, 19 (13), 1717-1725. doi: 10.1177/1352458513483887
Lucas, Robyn M., Ponsonby, Anne-Louise, Dear, Keith, Valery, Patricia C., Taylor, Bruce, van der Mei, Ingrid, McMichael, Anthony J., Pender, Michael P., Chapman, Caron, Coulthard, Alan, Kilpatrick, Trevor J., Stankovich, Jim, Williams, David and Dwyer, Terence (2013). Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient. Journal of Steroid Biochemistry and Molecular Biology, 136 (1), 300-308. doi: 10.1016/j.jsbmb.2013.01.011
Hughes, A. -M., Lucas, R. M., McMichael, A. J., Dwyer, T., Pender, M. P., van der Mei, I., Taylor, B. V., Valery, P., Chapman, C., Coulthard, A., Dear, K., Kilpatrick, T. J., Williams, D. and Ponsonby, A. -L. (2013). Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially. Clinical and Experimental Immunology, 172 (3), 466-474. doi: 10.1111/cei.12077
Lucas, Robyn M., Valery, Patricia, van der Mei, Ingrid, Dwyer, Terence, Pender, Michael P., Taylor, Bruce, Ponsonby, Anne-Louise and The Ausimmune Investigator Group (2013). Sun exposure over a lifetime in Australian adults from latitudinally diverse regions. Photochemistry and Photobiology, 89 (3), 737-744. doi: 10.1111/php.12044
Valery, P. C., Lucas, R. M., Williams, D. B., Pender, M. P., Chapman, C., Coulthard, A., Dear, K., Dwyer, T., Kilpatrick, T. J., McMichael, A. J., van der Mei, I., Taylor, B. V. and Ponsonby, A. -L. (2013). Occupational exposure and risk of central nervous system demyelination. American Journal of Epidemiology, 177 (9), 954-961. doi: 10.1093/aje/kws361
Pender, Michael P., Csurhes, Peter A., Pfluger, Casey M. M. and Burrows, Scott R. (2012). CD8(+) T cells far predominate over CD4(+) T cells in healthy immune response to Epstein-Barr virus infected lymphoblastoid cell lines. Blood, 120 (25), 5085-5087. doi: 10.1182/blood-2012-06-437285
Lill, Christina M., Liu, Tian, Schjeide, Brit-Marem, Roehr, Johannes T., Akkad, Denis A., Damotte, Vincent, Alcina, Antonio, Ortiz, Migual A., Arroyo, Rafa, Lopez de Lapuente, Aitzkoa, Blaschke, Paul, Winkelmann, Alexander, Gerdes, Lisa-Ann, Luessi, Felix, Fernadez, Oscar, Izquierdo, Guillermo, Antiguedad, Alfredo, Hoffjan, Sabine, Cournu-Reibeix, Isabelle, Gromoller, Silvana, Faber, Hans, Liebsch, Maria, Meissner, Esther, Chanvillard, Coralie, Touze, Emmanuel, Pico, Fernando, Corcia, Philippe, 19ANZgene Consortium, Bahlo, Melanie ... Zipp, Frauke (2012). Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. Journal of Medical Genetics, 49 (9), 558-562. doi: 10.1136/jmedgenet-2012-101175
Pender, Michael P., Csurhes, Peter A., Pfluger, Casey M.M. and Burrows, Scott R. (2012). CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 83 (3), 353-354. doi: 10.1136/jnnp-2011-300213
Ponsonby, A. -L., Lucas, R. M., van der Mei, I. A., Dear, K., Valery, P. C., Pender, M. P., Taylor, B. V., Kilpatrick, T. J., Coulthard, A., Chapman, C., Williams, D., McMichael, A. J. and Dwyer, T. (2012). Offspring number, pregnancy, and risk of a first clinical demyelinating event The AusImmune Study. Neurology, 78 (12), 867-874. doi: 10.1212/WNL.0b013e31824c4648
Lai, Jeffrey K.C., Lucas, Robyn M., Banks, Emily, Ponsonby, Anne-Louise, Ausimmune Investigator Group and Pender, Michael P. (2012). Variability in vitamin D assays impairs clinical assessment of vitamin D status. Internal Medicine Journal, 42 (1), 43-50. doi: 10.1111/j.1445-5994.2011.02471.x
Yan, Jun, Liu, Jia, Lin, Clement Yihao, Australia and New Zealand Multiple Sclerorsis Genetics Consortium, Csurhes, Peter A., Pender, Michael P., McCombe, Pamela A. and Greer, Judith M. (2012). Interleukin-6 Gene Promoter-572 C Allele may play a role in rate of disease progression in Multiple Sclerosis. International Journal of Molecular Sciences, 13 (10), 13667-13679. doi: 10.3390/ijms131013667
Pender, Michael P. (2012). Epstein–Barr virus in the multiple sclerosis brain – An evasive culprit. Multiple Sclerosis and Related Disorders, 1 (2), 61-63. doi: 10.1016/j.msard.2011.12.002
Pender, Michael (2012). CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency and steps to autoimmunity: a unifying hypothesis. Autoimmune Diseases, 2012 (1) 189096, 189096.1-189096.16. doi: 10.1155/2012/189096
Patsopoulos, Nikolaos A., Bayer Pharma MS Genetics Working Group, Steering Committee of Studies Evaluating IFNβ-1b, Steering Committee of a CCR1-Antagonist, ANZgene Consortium, GeneMSA, International Multiple Sclerosis Genetics Consortium, de Bakker, Paul I. W., Brown, Matthew A. and Pender, Michael P. (2011). Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of Neurology, 70 (6), 897-912. doi: 10.1002/ana.22609
Lucas, R. M., Hughes, A. M., Lay, M-L. J., Ponsonby, A-L., Dwyer, D. E., Taylor, B. V. and Pender, M. P. (2011). Epstein–Barr virus and multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 82 (10), 1142-1148. doi: 10.1136/jnnp-2011-300174
Pender, Michael P. (2011). The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis. Neuroscientist, 17 (4), 351-367. doi: 10.1177/1073858410381531
Pender, Michael P., Csurhes, Peter A ., Pfluger, Casey M. M. and Burrows, Scott R. (2011). Decreased CD8(+) T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes. BMC Neurology, 11 (1) 95, 95-1-95-6. doi: 10.1186/1471-2377-11-95
Lucas, R. M., Ponsonby, A.-L., Dear, K., Valery, P., Pender, M. P., Burrows, J. M., Burrows, S. R., Chapman, C., Coulthard, A., Dwyer, D. E., Dwyer, T., Kilpatrick, T., Lay, M.-L. J., McMichael, A. J., Taylor, B. V., van der Mei, I. A. F. and Williams, D. (2011). Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology, 77 (4), 371-379. doi: 10.1212/WNL.0b013e318227062a
Hughes, Ann Maree, Lucas, Robyn Marjorie, Ponsonby, Anne-Louise, Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor J., McMichael, Anthony J., Pender, Michael P., Taylor, Bruce V., Valery, Patricia, van der Mei, Ingrid A. F. and Williams, David (2011). The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: An Australian multicenter study. Pediatric Allergy and Immunology, 22 (3), 327-333. doi: 10.1111/j.1399-3038.2010.01099.x
Ritchie, Matthew E., Liu, Ruijie, Carvalho, Benilton S., The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Irizarry, Rafael A., Brown, Matthew A., Csurhes, Peter A., Danoy, Patrick, Greer, Judith M., Hadler, Johanna, Pryce, Karena and Pender, Michael P. (2011). Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips. BMC Bioinformatics, 12 (4) 68, 68.1-68.12. doi: 10.1186/1471-2105-12-68
Lucas, R.M., Ponsonby, A.L., Dear, K., Valery, P.C., Pender, M.P., Taylor, B.V., Kilpatrick, T.J., Dwyer, T., Coulthard, A., Chapman, C., van der Mei, I., Williams, D. and McMichael, A.J. (2011). Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology, 76 (6), 540-548. doi: 10.1212/WNL.0b013e31820af93d
Brennan, R. M., Burrows, J. M., Bell, M. J., Bromham, L., Csurhes, P. A., Lenarczyk, A., Sverndal, J., Klintenstedt, J., Pender, M. P. and Burrows, S. R. (2010). Strains of Epstein-Barr virus infecting multiple sclerosis patients. Multiple Sclerosis, 16 (6), 643-651. doi: 10.1177/1352458510364537
Szvetko, Attila, Jones, Ashleigh, Mackenzie, Jason, Tajouri, Lotti, Csurhes, Peter, Greer, Judith, Pender, Michael and Griffiths, Lyn (2010). Investigation of the [-/A](8) and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis. Neurological Research [electronic resource], 32 (4), 438-441. doi: 10.1179/174313209X405155
Taylor, Bruce V., Lucas, Robyn M., Dear, Keith, Kilpatrick, Trevor J., Pender, Michael P., van der Mei, Ingrid A. F., Chapman, Caron, Coulthard, Alan, Dwyer, Terence, McMichael, Anthony J., Valery, Patricia C., Williams, David and Ponsonby, Anne-Louise (2010). Latitudinal variation in incidence and type of first central nervous system demyelinating events. Multiple Sclerosis, 16 (4), 398-405. doi: 10.1177/1352458509359724
Bahlo, Melanie, Stankovich, Jim, Danoy, Patrick, Hickey, Peter F., Taylor, Bruce V., Browning, Sharon R., The Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Brown, Matthew A., Rubio, Justin P., Csurhes, Peter A., Greer, Judith, Pender, Michael P. and Pryce, Karena (2010). Saliva-derived DNA performs well in large-scale, high-density single-nucleotide polymorphism microarray studies. Cancer Epidemiology, Biomarkers and Prevention, 19 (3), 794-798. doi: 10.1158/1055-9965.EPI-09-0812
Lay, Meav-Lang J., Lucas, Robyn M., Ratnamohan, Mala, Taylor, Janette, Ponsonby, Anne-Louise, Dwyer, Dominic E., the Ausimmune Investigator Group (AIG) and Pender, Michael P. (2010). Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virology Journal, 7 (1) 252, 252.1-252.11. doi: 10.1186/1743-422X-7-252
Pender, Michael P. (2009). Does Epstein–Barr virus infection in the brain drive the development of multiple sclerosis?. Brain, 132 (12), 3196-3198. doi: 10.1093/brain/awp312
Lucas, Robyn M., Ponsonby, Anne-Louise, Dear, Keith, Taylor, Bruce V., Dwyer, Terence, McMichael, Anthony J., Valery, Patricia, van der Mei, Ingrid, Williams, David, Pender, Michael P., Chapman, Caron, Coulthard, Alan and Kilpatrick, Trevor (2009). Associations between silicone skin cast score, cumulative sun exposure, and other factors in the Ausimmune Study: A Multicenter Australian Study. Cancer Epidemiology, Biomarkers & Prevention, 18 (11), 2887-2894. doi: 10.1158/1055-9965.EPI-09-0191
Stankovich, J., Butzkueven, H., Marriott, M., Chapman, C., Tubridy, N., Tait, B.D., Varney, M.D., Taylor, B.V., Foote, S.J., Booth, D.R., Broadley, S., Greer, J.M., Griffiths, L.R., Heard, R.N., Lechner-Scott, M.J., Pender, M.J., Scott, R.J. and Stewart, G.J. (2009). HLA-DRB1 associations with disease susceptibility and clinical course in australians with multiple sclerosis. Tissue Antigens, 74 (1), 17-21. doi: 10.1111/j.1399-0039.2009.01262.x
Bahlo, Melanie, Booth, David R., Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R., Kilpatrick, Trevour J., Lechner-Scott, Jeanette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Clarke, Glynnis, Cox, Mathew B., Csurhes, Peter A., Danoy, Patrick, Drysdale, Karen, Field, Judith, Foote, Simon J., Greer, Judith M., Griffiths, Lyn R, Hadler, Johanna, McMorran, Brendan J., Jensen, Cathy J., Johnson, Laura J. ... Willoughby, Ernest (2009). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nature Genetics, 41 (7), 824-828. doi: 10.1038/ng.396
Pender, Michael P. (2009). Preventing and curing multiple sclerosis by controlling Epstein–Barr virus infection. Autoimmunity reviews, 8 (7), 563-568. doi: 10.1016/j.autrev.2009.01.017
Ganesvaran, G., Greer, J. M. and Pender, M. P. (2009). Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis. Multiple Sclerosis, 15 (6), 763-766. doi: 10.1177/1352458509103612
Mackenzie, Jason, Tajouri, Lotti, Szvetko, Attila, Weth, Verena, Moreau, Julie, Greer, Judith M., Csurhes, Peter A., Pender, Michael P. and Griffiths, Lyn R. (2009). Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population. Journal of the Neurological Sciences, 280 (1-2), 62-64. doi: 10.1016/j.jns.2009.01.026
Jones, Amanda L., Holliday, Elizabeth G., Mowry, Bryan J., McLean, Duncan E., McGrath, John J., Pender, Michael P. and Greer, Judith M. (2009). CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia. Brain Behavior and Immunity, 23 (3), 347-350. doi: 10.1016/j.bbi.2008.09.008
Szvetko, Attila L., Jones, Ashleigh, Mackenzie, Jason, Tajouri, Lotti, Csurhes, Peter A., Greer, Judith M., Pender, Michael P. and Griffiths, Lyn R. (2009). An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population. Brain Research, 1255, 148-152. doi: 10.1016/j.brainres.2008.12.017
Pender, Michael P., Csurhes, Peter A., Lenarczyk, Aleksandra, Pfluger, Casey M. M. and Burrows, S. R. (2009). Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 80 (5), 498-505. doi: 10.1136/jnnp.2008.161018
Pender, M. P., Lasserre, K. E., Del Mar, C., Kruesi, L. and Anuradha, S. (2009). Is Wikipedia unsuitable as a clinical information resource for medical students?. Medical Teacher, 31 (12), 1095-1096. doi: 10.3109/01421590903498412
Greer, Judith M., Csurhes, Peter A., Muller, Diane M. and Pender, Michael P. (2008). Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis. Journal of Immunology, 180 (9), 6402-6410. doi: 10.4049/jimmunol.180.9.6402
Pandian, Jeyaraj D., Rajah, Thulasi, Coulthard, Alan, Pender, Michael P. and Henderson, Robert D. (2008). Images in Neuroscience: Restricted diffusion on MR imaging of an acute cerebral lesion. Journal of Clinical Neuroscience, 15 (4), 456-487. doi: 10.1016/j.jocn.2007.02.007
Pandian, Jeyaraj D., Rajah, Thulasi, Coulthard, Alan, Pender, Michael P. and Henderson, Robert D. (2008). Restricted diffusion on MR imaging of an acute cerebral lesion. Journal of Clinical Neuroscience, 15 (4), 487-487. doi: 10.1016/j.jocn.2007.02.088
O'Sullivan, R. J., Brown, I. G. and Pender, M. P. (2008). Apneusis responding to buspirone in multiple sclerosis. Multiple Sclerosis, 14 (5), 705-707. doi: 10.1177/1352458507085802
Pender, Michael P. (2007). Tonic spasms and demyelinating lesions. Medicine Today, 8 (12), 51-52.
Pender, Michael P. (2007). Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system. Journal of Neuroimmunology, 191 (1-2), 26-38. doi: 10.1016/j.jneuroim.2007.09.015
Pender, Michael P. and Greer, Judith M. (2007). Immunology of multiple sclerosis. Current Allergy and Asthma Reports, 7 (4), 285-292. doi: 10.1007/s11882-007-0043-x
Pender, M. P. and Ferguson, S. M. (2007). Dysarthria and dysphagia due to the opercular syndrome in multiple sclerosis. Multiple Sclerosis, 13 (6), 817-819. doi: 10.1177/1352458506073481
Szvetko, A. L., Fowdar, J., Nelson, J., Colson, N., Tajouri, L., Csurhes, P. A., Pender, M. P. and Griffiths, L. R. (2007). No Association Between MTHFR A1298C and MTRR A66G Polymorphisms, and MS in an Australian Cohort. Journal of the Neurological Sciences, 252 (1), 49-52. doi: 10.1016/j.jns.2006.10.006
Tajouri, Lotti, Fernandez, Francesca, Tajouri, Sophie, Detriche, Geraldine, Szvetko, Attila, Colson, Natalie, Csurhes, Peter, Pender, M. P. and Griffiths, Lyn R. (2007). Allelic Variation Investigation of the Estrogen Receptor Within an Australian Multiple Sclerosis Population. Journal of the Neurological Sciences, 252 (1), 9-12. doi: 10.1016/j.jns.2006.09.018
Lucas, R. M., Ponsonby, A. L., McMichael, A. J., van der Mei, I., Chapman, C., Coulthard, A., Dear, K., Dwyer, T., Kilpatrick, T. J., Pender, M. P., Taylor, B., Valery, P. and Williams, D. (2007). Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function. Multiple Sclerosis, 13 (7), 827-839. doi: 10.1177/1352458507077174
Walker, David G., Chuah, Teong, Rist, Michael J. and Pender, Michael P. (2006). T-cell Apoptosis in Human Glioblastoma Multiforme: Implications for Immunotherapy. Journal of Neuroimmunology, 175 (1-2), 59-68. doi: 10.1016/j.jneuroim.2006.03.006
Tajouri, Lotti, Martin, Virginie, Gasparini, Claudia, Ovcaric, Micky, Curtain, Rob, Lea, Rod A., Haupt, Larisa M., Csurhes, Peter, Pender, Michael P. and Griffiths, Lyn R. (2006). Genetic Investigation of Methylenetetrahydrofolate Reductase (MTHFR) and Catechol-O-Methyl Transferase (COMT) in Multiple Sclerosis. Brain Research Bulletin, 69 (3), 327-331. doi: 10.1016/j.brainresbull.2006.01.005
Pender, Michael P. (2006). Multiple Sclerosis: Early Diagnosis and Comprehensive Management. Medicine Today, 7 (3), 14-21.
Henderson, Robert D. and Pender, Michael P. (2006). Lower Motor Neuron Weakness After Diving-Related Decompression. Neurology, 66 (3), 451-452. doi: 10.1212/01.wnl.0000196484.92748.b2
Csurhes, P. A., Sullivan, A-A., Green, K., Pender, M. P. and McCombe, P. A. (2005). T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neurology, Neurosurgery, and Psychiatry, 76 (10), 1431-1439. doi: 10.1136/jnnp.2004.052282
Pender, Michael P. (2005). CSF Testing for Multiple Sclerosis. The Lancet Neurology, 4 (9), 522-523. doi: 10.1016/S1474-4422(05)70151-4
Sellbach, Annabelle N. and Pender, Michael P. (2005). Multiple Sclerosis with Idiopathic Dilated Cardiomyopathy: A Case Report. European Neurology, 53 (4), 214-215. doi: 10.1159/000086733
Csurhes, Peter A., Sullivan, Alice-Ann, Green, Kerryn, Greer, Judith M., Pender, Michael P. and McCombe, Pamela A. (2005). Increased Circulating T Cell Reactivity to GM1 Ganglioside in Patients with Guillain-Barre Syndrome. Journal of Clinical Neuroscience, 12 (4), 409-415. doi: 10.1016/j.jocn.2004.04.006
Greer, J. M. and Pender, M. P. (2005). The Presence of Glutamic Acid at Positions 71 or 74 in Pocket 4 of the HLA-DR beta 1 Chain is Associated with the Clinical Course of Multiple Sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 76 (5), 656-662. doi: 10.1136/jnnp.2004.042168
Muller, Diane M., Pender, Michael P. and Greer, Judith M. (2005). Blood-Brain Barrier Disruption And Lesion Localisation In Experimental Autoimmune Encephalomyelitis With Predominant Cerebellar And Brainstem Involvement. Journal of Neuroimmunology, 160 (1-2), 162-169. doi: 10.1016/j.jneuroim.2004.11.011
Lane, S. W. and Pender, M. P. (2005). Intestinal Pseudo-Obstruction Complicating Multiple Sclerosis. Internal Medicine Journal, 35 (3), 191-192. doi: 10.1111/j.1445-5994.2004.00753.x
Jones, Amanda L., Mowry, Bryan J., Pender, Michael P. and Greer, Judith M. (2005). Immune Dysregulation and Self-Reactivity in Schizophrenia: Do Some Cases of Schizophrenia Have an Autoimmune Basis?. Immunology and Cell Biology, 83 (1), 9-17. doi: 10.1111/j.1440-1711.2005.01305.x
Pender, Michael P. (2005). Oligodendrocyte Apoptosis Before Immune Attack In Multiple Sclerosis?. Annals of Neurology, 57 (1), 158-158. doi: 10.1002/ana.20352
Tajouri, Lotti, Ovcaric, Micky, Curtain, Rob, Johnson, Matthew P., Griffiths, Lyn R., Csurhes, Peter, Pender, Michael P. and Lea, Rod A. (2005). Variation in The Vitamin D Receptor Gene is Associated With Multiple Sclerosis in an Australian Population. Journal of Neurogenetics, 19 (1), 25-38. doi: 10.1080/01677060590949692
Muller, Diane M., Pender, Michael P. and Greer, Judith M. (2004). Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis. Current Drug Targets - Inflammation and Allergy, 3 (3), 279-290. doi: 10.2174/1568010043343732
Tajouri, Lotti, Martin, Virginie, Ovcaric, Micky, Curtain, Rob P., Lea, Rod A., Csurhes, Peter, Pender, Michael P. and Griffiths, Lyn R. (2004). Investigation Of An Inducible Nitric Oxide Synthase Gene (NOS2A) Polymorphism In A Multiple Sclerosis Population. Brain Research Bulletin, 64 (1), 9-13. doi: 10.1016/j.brainresbull.2004.04.019
Greer, Judith M., Csurhes, Peter A., Pender, Michael P. and McCombe, Pamela A. (2004). Effect Of Gender On T-Cell Proliferative Responses To Myelin Proteolipid Protein Antigens In Patients With Multiple Sclerosis And Controls. Journal of Autoimmunity, 22 (4), 345-352. doi: 10.1016/j.jaut.2004.03.004
Tajouri, Lotti, Ferreira, Linda, Ovcaric, Micky, Curtain, Rob, Lea, Rod, Csurhes, Peter A., Pender, Michael P. and Griffiths, Lyn R. (2004). Investigation of a Neuronal Nitric Oxide Synthase Gene (NOS1) Polymorphism in a Multiple Sclerosis Population. Journal of the Neurological Sciences, 218 (1-2), 25-28. doi: 10.1016/j.jns.2003.10.006
Muller, D, Pender, M and Greer, JM (2004). CXCL1, CXCL2 and CXCR2 are highly expressed in an axial rotatory model of experimental autoinamune encephalomyelitis with polymorphonuclear cell infiltration. Multiple Sclerosis, 10, S97-S97.
Pender, MP and Greer, JM (2004). Increased circulating antibodies to an extracellular domain of myelin proteolipid protein in multiple sclerosis. Multiple Sclerosis, 10 (7032), S166-S166.
Pender, Michael P. (2004). The Pathogenesis Of Primary Progressive Multiple Sclerosis: Antibody-Mediated Attack And No Repair?. Journal of Clinical Neuroscience, 11 (7), 689-692. doi: 10.1016/j.jocn.2003.12.013
Pender, Michael P. (2003). Infection of Autoreactive B Lymphocytes with EBV, Causing Chronic Autoimmune Diseases. Trends in Immunology, 24 (11), 584-588. doi: 10.1016/j.it.2003.09.005
Pender, Michael P., Csurhes, Peter A., Wolfe, Nigel P., Hooper, Kaye D., Good, Michael F., McCombe, Pamela A. and Greer, Judith M. (2003). Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. Journal of Clinical Neuroscience, 10 (1), 63-66. doi: 10.1016/S0967-5868(02)00270-9
Pender, M. P. and Wolfe, N. P. (2002). Prevention of Autoimmune Attack and Disease Progression in Multiple Sclerosis: Current Therapies and Future Prospects. Internal Medicine Journal, 32 (11), 554-563. doi: 10.1046/j.1445-5994.2002.00269.x
Pender, Michael P. and Rist, Michael J. (2001). Apoptosis of Inflammatory Cells in Immune Control of the Nervous System: Role of Glia. Glia, 36 (2), 137-144. doi: 10.1002/glia.1103
Pender, Michael P. (2001). The Use of Interferon Beta at the Time of Initial Diagnosis of Multiple Sclerosis. Journal of Clinical Neuroscience, 8 (4), 381-382. doi: 10.1054/jocn.2001.0913
Harness, Jackie, Pender, Michael P. and McCombe, Pamela A. (2001). Cyclosporin A Treatment Modulates Cytokine mRNA Expression by Inflammatory Cells Extracted from the Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis Induced by Inoculation with Myelin Basic Protein. Journal of the Neurological Sciences, 187 (1-2), 7-16. doi: 10.1016/S0022-510X(01)00505-6
Hooper, Kaye D., Pender, Michael P., Webb, Penny M. and McCombe, Pam A. (2001). Use of traditional and complementary medical care by patients with Multiple Sclerosis in South-East Queensland. International Journal of MS Care, 3 (1), 13-28. doi: 10.7224/1537-2073-3.1.13
Gordon, F. L., Nguyen, K. B., White, C. A. and Pender, M. P. (2001). Rapid entry and downregulation of T Cells in the central nervous system During the reinduction of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 112 (1-2), 15-27. doi: 10.1016/S0165-5728(00)00341-6
Muller, Diane M., Pender, Michael P. and Greer, Judith M. (2000). A Neuropathological Analysis Of Experimental Autoimmune Encephalomyelitis With Predominant Brain Stem And Cerebellar Involvement And Differences Between Active And Passive Induction. Acta Neuropathologica, 100 (2), 174-182. doi: 10.1007/s004019900163
Pender, M. P. (2000). Multiple Sclerosis. Medical Journal of Australia, 172 (11), 556-562. doi: 10.5694/j.1326-5377.2000.tb124107.x
Sadatipour, B.T., Greer, J.M. and Pender, M.P. (2000). Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis - Reply. Annals of Neurology, 47 (5), 685-685.
Tayyebeh Sadatipour, B., Greer, Judith M. and Pender, Michael P. (2000). Reply. Annals of Neurology, 47 (5), 685-685. doi: 10.1002/1531-8249(200005)47:5<685::aid-ana28>3.0.co;2-k
Sadatipour, B. T., Greer, J. M. and Pender, M. P. (2000). Reply to letter by Giovanni et. al.. Annals of Neurology, 47 (5), 685-685.
White, Catherine A., Nguyen, Kim B. and Pender, Michael P. (2000). B Cell apoptosis in the central nervous system in experimental autoimmune Encephalomyelitis: Roles of B Cell CD95, CD95L and Bcl-2 expression. Journal of Autoimmunity, 14 (3), 195-204. doi: 10.1006/jaut.2000.0363
McDonald, N. D. and Pender, M. P. (2000). Autoimmune Hypothyroidism Associated with Interferon beta-1b Treatment in Two Patients with Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 30 (2), 278-279. doi: 10.1111/j.1445-5994.2000.tb00823.x
Henderson, R. D., Bain, C. J. and Pender, M. P. (2000). The Occurrence of Autoimmune Diseases in Patients with Multiple Sclerosis and Their Families. Journal of Clinical Neuroscience, 7 (5), 434-437. doi: 10.1054/jocn.2000.0693
Pender, Michael P., Csurhes, Peter A., Greer, Judith M., Mowat, Paul D., Henderson, Robert D., Cameron, Kaye D., Purdie, David M., McCombe, Pamela A. and Good, Michael F. (2000). Surges of Increased T Cell Reactivity to an Encephalitogenic Region of Myelin Proteolipid Protein Occur More Often in Patients with Multiple Sclerosis than in Healthy Subjects. Journal of Immunology, 165 (9), 5322-5331. doi: 10.4049/jimmunol.165.9.5322
Pender, Michael P. (1999). Recent Progress In The Diagnosis And Treatment Of Multiple Sclerosis. Journal of Clinical Neuroscience, 6 (5), 367-372. doi: 10.1016/S0967-5868(99)90026-7
Pender, Michael P. (1999). Activation-Induced Apoptosis of Autoreactive and Alloreactive T Lymphocytes in the Target Organ as a Major Mechanism of Tolerance. Immunology and Cell Biology, 77 (3), 216-223. doi: 10.1046/j.1440-1711.1999.00818.x
Nguyen, Kim B. and Pender, Michael P. (1999). Survival And Mitosis Of Myelinating Oligodendrocytes In Experimental Autoimmune Encephalomyelitis: An Immunocytochemical Study With Rip Antibody. Acta Neuropathologica, 98 (1), 39-47. doi: 10.1007/s004010051049
McCombe, Pamela A., Harness, J. and Pender, M. P. (1999). Effects of Cyclosporin A Treatment on Clinical Course and Inflammatory Cell Apoptosis in Experimental Autoimmune Encephalomyelitis Induced in Lewis Rats by Inoculation with Myelin Basic Protein. Journal of Neuroimmunology, 97 (1-2), 60-69. doi: 10.1016/S0165-5728(99)00047-8
Pender, M. P. (1999). Immunoneurology. Journal of Clinical Neuroscience, 6 (3), 272-273. doi: 10.1016/s0967-5868(99)90525-8
Bartley, Paul P., Pender, Michael P., Woods, Marion L., Walker, Duncan, Douglas, James A., Allworth, Anthony M., Eisen, Damon P. and Currie, Bart J. (1999). Spinal Cord Disease Due To Melioidosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93 (2), 175-176. doi: 10.1016/S0035-9203(99)90299-7
Hulcombe, Jane E., Bradfield, John M., Tannenberg, Anthony E. G. and Pender, Michael P. (1999). Balo's Concentric Sclerosis In A Woman From Papua New Guinea. Journal of Clinical Neuroscience, 6 (1), 46-48. doi: 10.1016/S0967-5868(99)90603-3
McCombe, P. A., Nickson, I. and Pender, M. P. (1998). Cytokine Expression by Inflammatory Cells Obtained from the Spinal Cords of Lewis Rats with Experimental Autoimmune Encephalomyelitis Induced by Inoculation with Myelin Basic Protein and Adjuvants. Journal of Neuroimmunology, 88 (1-2), 30-38. doi: 10.1016/S0165-5728(98)00068-X
Henderson, R. D., Saltissi, D. and Pender, M. P. (1998). Goodpasture's Syndrome Associated with Multiple Sclerosis. Acta Neurologica Scandinavica, 98 (2), 134-135. doi: 10.1111/j.1600-0404.1998.tb01733.x
White, C. A., McCombe, P. A. and Pender, M. P. (1998). Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune Encephalomyelitis through a mechanism not involving Fas (CD95). International Immunology, 10 (7), 935-941. doi: 10.1093/intimm/10.7.935
Ishigami, Tsuyoshi, White, Catherine A. and Pender, Michael P. (1998). Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. European Journal of Immunology, 28 (5), 1626-1635. doi: 10.1002/(SICI)1521-4141(199805)28:05<1626::AID-IMMU1626>3.0.CO;2-B
Pender, Michael P. (1998). Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet, 351 (9107), 978-981. doi: 10.1016/S0140-6736(05)60642-3
Pender, Michael P. (1998). Genetically Determined Failure Of Activation-Induced Apoptosis Of Autoreactive T Cells As A Cause Of Multiple Sclerosis. The Lancet, 351 (9107), 978-981.
White, Catherine A., McCombe, Pamela A. and Pender, Michael P. (1998). The roles of Fas, Fas Ligand and Bcl-2 in T Cell apoptosis in the central nervous system in experimental autoimmune Encephalomyelitis. Journal of Neuroimmunology, 82 (1), 47-55. doi: 10.1016/S0165-5728(97)00187-2
Henderson, R. D., Ohlrich, G. D. and Pender, M. P. (1998). Guillain-Barre Syndrome and Optic Neuritis after Mycoplasma Pneumoniae Infection. Australian and New Zealand Journal of Medicine, 28 (4), 481-482. doi: 10.1111/j.1445-5994.1998.tb02093.x
Sadatipour, B. Tayyebeh, Greer, Judith M. and Pender, Michael P. (1998). Increased Circulating Antiganglioside Antibodies in Primary and Secondary Progressive Multiple Sclerosis. Annals of Neurology, 44 (6), 980-983. doi: 10.1002/ana.410440621
Nguyen, Kim B. and Pender, Michael P. (1998). Phagocytosis of Apoptotic Lymphocytes by Oligodendrocytes In experimental Autoimmune Encephalomyelitis. Acta Neuropathologica, 95 (1), 40-46. doi: 10.1007/s004010050763
Ishigami, Tsuyoshi, White, Catherine A. and Pender, Michael P. (1998). Soluble Antigen Therapy Induces Apoptosis Of Autoreactive T Cells Preferentially In The Target Organ Rather Than In The Peripheral Lymphoid Organs. European Journal of Immunology, 28 (5), 1626-1635. doi: 10.1002/(SICI)1521-4141(199805)28:05<1626::AID-IMMU1626>3.0.CO;2-B
Greer, J. M., Csurhes, P. A., Cameron, K. D., McCombe, P. A., Good, M. F. and Pender, M. P. (1997). Increased Immunoreactivity to Two Overlapping Peptides of Myelin Proteolipid Protein in Multiple Sclerosis. Brain, 120 (8), 1447-1460. doi: 10.1093/brain/120.8.1447
Pender, M. P., Csurhes, P. A., Houghten, R. A., McCombe, P. A. and Good, M. F. (1997). Corrigendum to "A Study Of Human T-Cell Lines Generated From Multiple Sclerosis Patients And Controls By Stimulation With Peptides Of Myelin Basic Protein" (J. Neuroimmunol. 70, 65-74). Journal of Neuroimmunology, 73 (1-2), 213-213.
Pender, M. P., Csurhes, P. A., Houghten, R. A., McCombe, P. A. and Good, M. F. (1997). Erratum: A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein (J. Neuroimmunol. 70, 65-74 (1996)). Journal of Neuroimmunology, 73 (1-2), 213-213. doi: 10.1016/S0165-5728(96)00222-6
Nguyen, Kim B., McCombe, Pamela A. and Pender, Michael P. (1997). Increased apoptosis of T lymphocytes and macrophages in the central and peripheral nervous systems of Lewis rats with experimental autoimmune encephalomyelitis treated with dexamethasone. Journal of Neuropathology and Experimental Neurology, 56 (1), 58-69. doi: 10.1097/00005072-199701000-00006
McCombe, P. A., Nickson, I., Tabi, Z. and Pender, M. P. (1996). Corticosteroid Treatment Of Experimental Autoimmune Encephalomyelitis In The Lewis Rat Results in Loss of V Beta 8.2+ and Myelin Basic Protein-Reactive Cells from the Spinal Cord, with Increased Total T-Cell Apoptosis but Reduced Apoptosis of V Beta 8.2+. Journal of Neuroimmunology, 70 (2), 93-101. doi: 10.1016/S0165-5728(96)00043-4
Pender, M. P., Csurhes, P. A., Houghten, R. A., McCombe, P. A. and Good, M. F. (1996). A Study Of Human T-Cell Lines Generated From Multiple Sclerosis Patients And Controls By Stimulation With Peptides Of Myelin Basic Protein. Journal of Neuroimmunology, 70 (1), 65-74. doi: 10.1016/S0165-5728(96)00105-1
Nguyen, KB and Pender, MP (1996). A simple technique for flat osmicating and flat embedding of immunolabelled vibratome sections of the rat spinal cord for light and electron microscopy (vol 65, pg 51, 1996). JOURNAL OF NEUROSCIENCE METHODS, 68 (2), 308-309. doi: 10.1016/0165-0270(96)00078-7
Pender, M. P. (1996). Interferon Beta in the Management of Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 26 (3), 343-343. doi: 10.1111/j.1445-5994.1996.tb01919.x
Nguyen, Kim B. and Pender, Michael P. (1996). A simple technique for flat osmicating and flat embedding of immunolabelled vibratome sections of the rat spinal cord for light and electron microscopy. Journal of Neuroscience Methods, 65 (1), 51-54. doi: 10.1016/0165-0270(95)00145-X
McCombe, P. A., Nickson, I., Tabi, Z. and Pender, M. P. (1996). Apoptosis of Vβ8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. Journal of Neurological Sciences, 139 (1), 1-6. doi: 10.1016/S0022-510X(96)00005-6
Read, Stephen J., Harrison, John D. and Pender, Michael P. (1996). Progressive Visual Loss: An Unusual Presentation Of Multiple Sclerosis. Journal of Clinical Neuroscience, 3 (3), 264-267. doi: 10.1016/S0967-5868(96)90063-6
Pender, M. P. (1996). Recent Advances in the Understanding, Diagnosis and Management of Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 26 (2), 157-161. doi: 10.1111/j.1445-5994.1996.tb00878.x
Read, Stephen J., Leggett, Barbara A. and Pender, Michael P. (1995). Gastroparesis With Multiple Sclerosis. The Lancet, 346 (8984), 1228.
Read, Stephen J., Leggett, Barbara A. and Pender, Michael P. (1995). Gastroparesis with multiple sclerosis. Lancet, 346 (8984), 1228-1228. doi: 10.1016/S0140-6736(95)92932-0
Chalk, Jonathan B., McCombe, Pamela A. and Pender, Michael P. (1995). Conduction abnormalities are restricted to the central nervous system in experimental autoimmune encephalomyelitis induced by inoculation with proteolipid protein but not with myelin basic protein (Vol 117, pg 975, 1994). Brain, 118, 1073-1073. doi: 10.1093/brain/118.4.1073-a
Pender, M. P., Tabi, Zsuzsanna, Nguyen, K. B. and McCombe, Pamela A. (1995). The Proximal Peripheral Nervous System Is A Major Site Of Demyelination In Experimental Autoimmune Encephalomyelitis Induced In The Lewis Rat By A Myelin Basic Protein-Specific T Cell. Acta Neuropathologica, 89 (6), 527-531. doi: 10.1007/s004010050284
ReadSJ, Crawford, D. H. G., PenderMP and GrahamMacdonald (1995). Trigeminal Sensory Neuropathy Induced by Interferon-Alpha Therapy. Australian and New Zealand Journal of Medicine, 25 (1), 54-54. doi: 10.1111/j.1445-5994.1995.tb00580.x
Chalk, Jonathan B., McCombe, Pamela A. and Pender, Michael P. (1995). Restoration of conduction in the spinal roots correlates with clinical recovery from experimental autoimmune encephalomyelitis. Muscle and Nerve, 18 (10), 1093-1110. doi: 10.1002/mus.880181005
Tabi, Zsuzsanna, McCombe, Pamela A. and Pender, Michael P. (1995). Antigen-Specific Down-Regulation of Myelin Basic Protein-Reactive T Cells During Spontaneous Recovery From Experimental Autoimmune Encephalomyelitis: Further Evidence of Apoptotic Deletion of Autoreactive T Cells in the Central Nervous System. International Immunology, 7 (6), 967-973. doi: 10.1093/intimm/7.6.967
Chalk, Jonathan B., McCombe, Pamela A., Smith, Ross and Pender, Michael P. (1994). Clinical And Histological Findings in Proteolipid Protein-Induced Experimental Autoimmune Encephalomyelitis (EAE) In The Lewis Rat. Distribution of Demyelination Differs From That in EAE Induced by Other Antigens. Journal of the Neurological Sciences, 123 (1-2), 154-161. doi: 10.1016/0022-510X(94)90218-6
Nguyen, Kim B., McCombe, Pamela A. and Pender, Michael P. (1994). Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. Journal of Autoimmunity, 7 (2), 145-152. doi: 10.1006/jaut.1994.1011
Chalk, Jonathan B., McCombe, Pamela A. and Pender, Michael P. (1994). Conduction abnormalities are restricted to the central nervous system in experimental autoimmune encephalomyelitis induced by inoculation with proteolipid protein but not with myelin basic protein. Brain, 117 (5), 975-986. doi: 10.1093/brain/117.5.975
Tabi, Zsuzsanna, McCombe, Pamela A. and Pender, Michael P. (1994). Apoptotic Elimination Of V beta 8.2+ Cells From The Central Nervous System During Recovery From Experimental Autoimmune Encephalomyelitis Induced By The Passive Transfer Of V beta 8.2+ Encephalitogenic T Cells. European Journal of Immunology, 24 (11), 2609-2617. doi: 10.1002/eji.1830241107
McCombe, P. A., de Jersey, J. and Pender, M. P. (1994). Inflammatory Cells, Microglia and MHC Class II Antigen-Positive Cells in the Spinal Cord of Lewis Rats with Acute and Chronic Relapsing Experimental Autoimmune Encephalomyelitis. Journal of Neuroimmunology, 51 (2), 153-167. doi: 10.1016/0165-5728(94)90077-9
PENDER, MP (1993). NEUROLOGICAL SIGNS IN INFLAMMATORY DEMYELINATION. ANNALS OF NEUROLOGY, 33 (5), 559-559. doi: 10.1002/ana.410330524
Johnson, David W., Whiting, Gerald and Pender, Michael P. (1993). Cervical Self-Manipulation and Stroke. Medical Journal of Australia, 158 (4), 290.
Johnson, D.W., Whiting, G. and Pender, M.P. (1993). Cervical self-manipulation and stroke. Medical Journal of Australia, 158 (4), 290-290.
Bates, P. R., McCombe, P. A., Sheean, G. L., Cooksley, W. G. E. and Pender, M. P. (1993). Failure to Detect Measles Virus Sequences in Lymphocytes of Patients with Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 23 (1), 55-55. doi: 10.1111/j.1445-5994.1993.tb00539.x
Pender, Michael P. (1993). Neurological signs in inflammatory demyelination. Annals of Neurology, 33 (5), 559-559. doi: 10.1002/ana.410330524
McCombe, P. A., Fordyce, B. W., de Jersey, J., Yoong, G. and Pender, M. P. (1992). Expression of CD45RC and Ia Antigen in the Spinal Cord in Acute Experimental Allergic Encephalomyelitis: An Immunocytochemical and Flow Cytometric Study. Journal of the Neurological Sciences, 113 (2), 177-186. doi: 10.1016/0022-510X(92)90245-G
McCombe, P. A., Sheean, G. L., McLaughlin, D. B. and Pender, M. P. (1992). Vestibular and Ventilatory Dysfunction in Sensory and Autonomic Neuropathy Associated With Primary Sjogren's Syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 55 (12), 1211-1212. doi: 10.1136/jnnp.55.12.1211
Read, Stephen J., Schapel, Graham J. and Pender, Michael P. (1992). Acute Transverse Myelitis After Tetanus Toxoid Vaccination. The Lancet, 339 (8801), 1111-1112.
Read, Stephen J., Schapel, Graham J. and Pender, Michael P. (1992). Acute transverse myelitis after tetanus toxoid vaccination. Lancet, 339 (8801), 1111-1112. doi: 10.1016/0140-6736(92)90703-6
McCombe, P. A., van der Kreek, S. A. and Pender, M. P. (1992). Neuropathological Findings In Chronic Relapsing Experimental Allergic Neuritis Induced In The Lewis Rat By Inoculation With Intradural Root Myelin And Treatment With Low Dose Cyclosporin A. Neuropathology and Applied Neurobiology, 18 (2), 171-187. doi: 10.1111/j.1365-2990.1992.tb00778.x
McCombe, P. A., McLaughlin, D. B., Chalk, J. B., Brown, N. N., McGill, J. J. and Pender, M. P. (1992). Spasticity and White Matter Abnormalities In Adult Phenylketonuria. Journal of Neurology, Neurosurgery and Psychiatry, 55 (5), 359-361. doi: 10.1136/jnnp.55.5.359
Pender, Michael P., McCombe, Pamela A., Yoong, Gerald and Nguyen, Kim B. (1992). Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance. Journal of Autoimmunity, 5 (4), 401-410. doi: 10.1016/0896-8411(92)90001-7
Stanley, Glenn P., McCombe, Pamela A. and Pender, Michael P. (1992). Focal conduction block in the dorsal root ganglion in experimental allergic neuritis. Annals of Neurology, 31 (1), 27-33. doi: 10.1002/ana.410310106
Pender, M. P., Nguyen, K. B., McCombe, P. A. and Kerr, J. F. R. (1991). Apoptosis in the Nervous System in Experimental Allergic Encephalomyelitis. Journal of the Neurological Sciences, 104 (1), 81-87. doi: 10.1016/0022-510X(91)90219-W
McCombe, P. A., Klestov, A. C., Tannenberg, A. E., Chalk, J. B. and Pender, M. P. (1991). Sensorimotor peripheral neuropathy in rheumatoid arthritis. Clinical and experimental neurology, 28, 146-153.
Stanley, G. P. and Pender, M. P. (1991). The Pathophysiology of Chronic Relapsing Experimental Allergic Encephalomyelitis in the Lewis Rat. Brain, 114 (4), 1827-1853. doi: 10.1093/brain/114.4.1827
McCombe, P. A., Klestov, A. C., Tannenberg, A. E., Chalk, J. B. and Pender, M. P. (1991). Sensorimotor Peripheral Neuropathy in Rheumatoid Arthritis. Clinical and Experimental Neurology, 28, 146-53.
Chalk, J. B., George, J., McCombe, P. A., Tannenberg, A. E. G., Ward, M. and Pender, M. P. (1991). Cronkhite-Canada Syndrome Associated with Peripheral Neuropathy. Australian and New Zealand Journal of Medicine, 21 (3), 379-379. doi: 10.1111/j.1445-5994.1991.tb04710.x
McCombe, P. A. and Pender, M. P. (1991). Lack Of Neurological Abnormalities In Lewis Rats With Experimental Chronic Serum Sickness. Clinical and Experimental Neurology, 28, 139-145.
Pender, M. P. (1991). Cyclosporine and Multiple Sclerosis. Annals of Neurology, 29 (2), 226-226. doi: 10.1002/ana.410290224
McCombe, P. A., van der Kreek, S. A. and Pender, M. P. (1990). The Effects of Prophylactic Cyclosporin A on Experimental Allergic Neuritis (EAN) in the Lewis Rat: Induction of Relapsing EAN Using Low Dose Cyclosporin A. Journal of Neuroimmunology, 28 (2), 131-140. doi: 10.1016/0165-5728(90)90027-K
McCombe, P. A., Chalk, J. B. and Pender, M. P. (1990). Familial Occurrence of Multiple Sclerosis with Thyroid Disease and Systemic Lupus Erythematosus. Journal of the Neurological Sciences, 97 (2-3), 163-171. doi: 10.1016/0022-510X(90)90215-9
Pender, M. P., Stanley, G. P., Yoong, G. and Nguyen, K. B. (1990). The Neuropathology Of Chronic Relapsing Experimental Allergic Encephalomyelitis Induced In The Lewis Rat By Inoculation With Whole Spinal Cord And Treatment With Cyclosporin A. Acta Neuropathologica, 80 (2), 172-183. doi: 10.1007/BF00308921
Powell, Elizabeth E., Pender, Michael P., Chalk, Jonathan B., Parkin, Philip J., Strong, Russell, Lynch, Stephen, Kerlin, Paul, Cooksley, W. Graham, Cheng, Wendy and Powell, Lawrie W. (1990). Improvement in Chronic Hepatocerebral Degeneration Following Liver Transplantation. Gastroenterology, 98 (4), 1079-1082. doi: 10.1016/0016-5085(90)90036-Z
Pender, M. P., Nguyen, K. B. and Willenborg, D. O. (1989). Demyelination and Early Remyelination in Experimental Allergic Encephalomyelitis Passively Transferred With Myelin Basic Protein-Sensitized Lymphocytes in the Lewis Rat. Journal of Neuroimmunology, 25 (2-3), 125-142. doi: 10.1016/0165-5728(89)90130-6
McCombe, P. A., Chalk, J. B., Searle, J. W., Tannenberg, A. E. G., Smith, J. J. and Pender, M. P. (1989). Progressive Encephalomyelitis With Rigidity: A Case Report With Magnetic Resonance Imaging Findings. Journal of Neurology, Neurosurgery and Psychiatry, 52 (12), 1429-1431. doi: 10.1136/jnnp.52.12.1429
Pender, M. P. and Chalk, J. B. (1989). Connective Tissue Disease Mimicking Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 19 (5), 469-472. doi: 10.1111/j.1445-5994.1989.tb00309.x
Pender, M. P. (1989). Recovery from Acute Experimental Allergic Encephalomyelitis in the Lewis Rat: Early Restoration of Nerve Conduction and Repair by Schwann Cells and Oligodendrocytes. Brain, 112 (2), 393-416. doi: 10.1093/brain/112.2.393
Nguyen, K. B. and Pender, M. P. (1989). Assessment of Demyelination in Glycol Methacrylate Sections: a New Protocol for Cresyl Fast Violet Staining. Stain Technology, 64 (4), 163-167. doi: 10.3109/10520298909106993
Hansen, L. A. and Pender, M. P. (1989). Hypothermia Due to an Ascending Impairment of Shivering in Hyperacute Experimental Allergic Encephalomyelitis in the Lewis Rat. Journal of the Neurological Sciences, 94 (1-3), 231-240. doi: 10.1016/0022-510X(89)90233-5
Chalk, J. B., Patterson, M. C. and Pender, M. P. (1989). An Intracranial Arteriovenous Malformation and Palatal Myoclonus Related to Pseudoxanthoma Elasticum. Australian and New Zealand Journal of Medicine, 19 (2), 141-143. doi: 10.1111/j.1445-5994.1989.tb00224.x
Pender, M. P. (1988). The Pathophysiology of Myelin Basic Protein-Induced Acute Experimental Allergic Encephalomyelitis in the Lewis Rat. Journal of the Neurological Sciences, 86 (2-3), 277-289. doi: 10.1016/0022-510X(88)90105-0
Pender, M. P. (1988). The Pathophysiology of Acute Experimental Allergic Encephalomyelitis Induced by Whole Spinal Cord in the Lewis Rat. Journal of the Neurological Sciences, 84 (2-3), 209-222. doi: 10.1016/0022-510X(88)90126-8
Pender, Michael P. (1988). Demyelination of the Peripheral Nervous System Causes Neurologic Signs in Myelin Basic Protein-Induced Experimental Allergic Encephalomyelitis - Implications for the Etiology of Multiple Sclerosis. Annals of the New York Academy of Sciences, 540 (1), 732-734. doi: 10.1111/j.1749-6632.1988.tb27229.x
Pender, M. P. (1987). Demyelination and Neurological Signs in Experimental Allergic Encephalomyelitis. Journal of Neuroimmunology, 15 (1), 11-24. doi: 10.1016/0165-5728(87)90003-8
Pender, M. P. (1986). Ascending Impairment of Nociception in Rats with Experimental Allergic Encephalomyelitis. Journal of the Neurological Sciences, 75 (3), 317-328. doi: 10.1016/0022-510X(86)90079-1
Pender, M. P. (1986). Conduction Block Due To Demyelination At The Ventral Root Exit Zone In Experimental Allergic Encephalomyelitis. Brain Research, 367 (1-2), 398-401. doi: 10.1016/0006-8993(86)91627-6
Pender, M. P. and Sears, T. A. (1986). Involvement of the Dorsal Root Ganglion in Acute Experimental Allergic Encephalomyelitis in the Lewis Rat - A Histological and Electrophysiological Study. Journal of Neurological Sciences, 72 (2-3), 231-242. doi: 10.1016/0022-510X(86)90011-0
PENDER, MP and SEARS, TA (1986). INVOLVEMENT OF THE DORSAL-ROOT GANGLION IN ACUTE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE LEWIS RAT - A HISTOLOGICAL AND ELECTROPHYSIOLOGICAL STUDY. JOURNAL OF THE NEUROLOGICAL SCIENCES, 72 (2-3), 231-242. doi: 10.1016/0022-510X(86)90011-0
Pender, M. P. (1985). A Simple Method For High Resolution Light Microscopy Of Nervous Tissue. Journal of Neuroscience Methods, 15 (3), 213-218. doi: 10.1016/0165-0270(85)90100-1
Pender, M. P. and Sears, T. A. (1985). Vulnerability of the Dorsal Root Ganglion in Experimental Allergic Encephalomyelitis. Clinical and Experimental Neurology, 21, 211-223.
Pender, M. P. and Sears, T. A. (1984). The Pathophysiology of Acute Experimental Allergic Encephalomyelitis in the Rabbit. Brain, 107 (3), 699-726. doi: 10.1093/brain/107.3.699
Pender, M. P. and Sears, T. A. (1982). Conduction Block in the Peripheral Nervous System in Experimental Allergic Encephalomyelitis. Nature, 296 (5860), 860-862. doi: 10.1038/296860a0
Conference Papers
Pender, M. P., Hodgkinson, S., Broadley, S., Lindsey, J. W., Ioannides, Z. A., Aftab, B. T., Munson, D., Rasor, K., Forozan, F., Foubert, P., Gamelin, L., Feng, A. and Willmer, J. (2019). Preliminary phase 1 safety of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus (EBV)-targeted T-cell immunotherapy for patients with progressive multiple sclerosis (MS). 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 29-July 2, 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
Pender, M., Hodgkinson, S., Broadley, S., Lindsey, J., Ioannides, Z., Munson, D., Rasor, K., Forozan, F., Foubert, P., Aftab, B., Gamelin, L., Ye, W. and Willmer, J. (2019). Preliminary safety and efficacy of ATA188, a pre-manufactured, unrelated donor (off-the-shelf, allogeneic) Epstein-Barr virus-targeted T-cell immunotherapy for patients with progressive forms of multiple sclerosis. 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11-13 September 2019 . London, United Kingdom: Sage Publications.
Bagert, Bridget, Greer, Judith, Savage, Hannah, Beasley, Shannon, Juba, Gracy and Pender, Michael (2018). Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo. 70th Annual Meeting of the American Academy of Neurology (AAN), Los Angeles, California, 21-27 April 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins.
Pender, M. P., Csurhes, P. A., Smith, C., Douglas, N. L., Neller, M. A., Beagley, L., Rehan, S., Hopkins, T. J., Thompson, K. M., Blum, S., Green, K. A., Ioannides, Z. A., Coulthard, A., Hooper, K. D., Burrows, S. R. and Khanna, R. (2017). Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, France, 25-28 October 2017. London, United Kingdom: Sage Publications.
Pender, Michael, Csurhes, Peter, Smith, Corey, Douglas, Nanette, Neller, Michelle, Beagley, Leone, Rehan, Sweera, Hopkins, Tracey, Thompson, Kate, Blum, Stefan, Green, Kerryn, Ioannides, Zara, Coulthard, Alan, Hooper, Kaye, Burrows, Scott and Khanna, Rajiv (2017). Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial. 69th Annual Meeting of the American Academy of Neurology (AAN), Boston, Massachusetts, 22-28 April 2017. Philadelphia, PA, United States: Lippincott Williams & Wilkins.
Greer, J. M., Muller, D. M., Beasley, S. J., Trifilieff, E. and Pender, M. P. (2016). Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis. ICI 2016 International Congress of Immunology, Melbourne, Australia, 21–26 August 2016. Weinheim, Germany: Wiley.
Pender, Michael, Csurhes, Peter and Burrows, Scott (2015). Impaired T cell control of Epstein-Barr virus infection in multiple sclerosis. MS Research Australia Progress in MS Research Conference, Melbourne, Australia, Oct 29-30, 2015. London, EC1Y 1SP United Kingdom: SAGE PUBLICATIONS LTD. doi: 10.1177/1352458515616527
Cloake, Nancy, Yan, Jun, Pender, Michael, Aminian, Atefeh and Greer, Judith (2014). PLP1 mutations in patients with multiple sclerosis: Identification of a new mutation and analysis of in vitro effects of PLP1 mutations. 12th International Congress of Neuroimmunology (ISNI), Mainz Germany, 9-13 November 2014. Amsterdam, The Netherlands: Elsevier. doi: 10.1016/j.jneuroim.2014.08.268
Yan, Jun, Greer, Judith, Mccombe, Pamela, Pender, Michael and Consortium, Anzgene (2014). Characterization of genetic variants in the NFKBIA promoter region in multiple sclerosis. 12th International Congress of Neuroimmunology (ISNI), Mainz, Germany, Nov 09-13, 2014. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.jneuroim.2014.08.141
Pender, M. P., Csurhes, P. A., Smith, C., Beagley, L., Hooper, K. D., Raj, M., Coulthard, A., Burrows, S. R. and Khanna, R. (2013). Treatment of secondary progressive multiple sclerosis by boosting CD8 T cell immunity to Epstein-Barr virus using a novel adoptive immunotherapy. 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen Denmark, 2 - 5 October 2013. London, United Kingdom: Sage Publications Ltd.. doi: 10.1177/1352458513502429
Yan, J., Pender, M.P., Liu, J., McCombe, P.A., Greer, J.M. and ANZgene Consortium (2012). Investigation of gene mutations in the NFKBIA promoter region in patients with multiple sclerosis. Progress in MS Research Conference 2011, Melbourne, VIC, Australia, 26-28 October 2011. London, United Kingdom: Sage Publications.
Greer, J.M., Moxey, N.C., Pender, M.P. and Trifilieff, E. (2012). Development of specific therapeutic agents for multiple sclerosis (MS). Progress in MS Research Conference 2011, Melbourne, VIC, Australia, 26-28 October 2011. London, United Kingdom: Sage Publications.
Pender, M.P. (2012). Building the hypothesis: CD8 T cell deficiency impairs immune control of Epstein-Barr virus infection in multiple sclerosis and worsens with age. Progress in MS Research Conference 2011, Melbourne, VIC, Australia, 26-28 October 2011. London, United Kingdom: Sage Publications.
Greer, Judith and Pender, Michael (2012). Consistent patterns of clinical and laboratory findings in patients with co-existent autoimmune thyroid disease and autoimmune demyelinating disease in the central nervous system. 11th International Congress of Neuroimmunology (ISNI), Boston MA., United States, 4-8 November 2012. Amsterdam, The Netherlands: Elsevier.
Pender, M. P., Csurhes, P. A., Pfluger, C. M. M. and Burrows, S. R. (2011). CD8+T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosis. LONDON: SAGE PUBLICATIONS LTD.
Jones, Amanda, Mowry, Bryan, Pender, Michael and Greer, Judith (2010). Elevated levels of autoantibodies against neurotransmitter receptor-related molecules in schizophrenia. 10th Congress of the International-Society-of-Neuroimmunology (ISNI), Sitges SPAIN, OCT 26-30, 2010.
Ponsonby, AL, Lucas, RM, van der Mei, I, Dear, K, Taylor, BV, McMichael, AJ, Valery, P, Dwyer, T, Chapman, C, Pender, MP, Coulthard, A, Williams, D and Kilpatrick, TJ (2010). Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelination. 15th Annual Meeting of the Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, San Antonio TX, JUN, 2010.
Lucas, Robyn M., Ponsonby, Ane-Louise, Burrows, J., Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terence, Kilpatrick, Trevor J., McMichael, Anthony J., Taylor, Bruce V., Valery, Patricia, van der Mei, Ingrid, Williams, D and Pender, Michael P. (2010). Epstein Barr viral infection and onset of central nervous system demyelination. 15th Annual ACTRIMS Meeting Americas Committee for Treatment and Research in Multiple Sclerosis, San Antonio, TX, United States, 5 June 2010. London, United Kingdom: Sage Publications. doi: 10.1177/13524585100160081301
Lucas, Robyn M., Ponsonby, Anne-Louise, Dear, Keith, McMichael, Anthony J., Pender, Michael P., Taylor, Bruce V., Chapman, Caron, Coulthard, Alan, Dwyer, Terence, Kilpatrick, Trevor J., Valery, Patricia, van der Mei, David Ingrid and Williams, David (2009). Lower vitamin D status at first clinical diagnosis of central nervous system demyelination compared to matched controls. 14th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis/Consortium for Multiple Sclerosis Centers, Atlanta GA, 27-30 May 2009. United Kingdom: Sage Publications. doi: 10.1177/1352458509348507
Pender, Michael P, Lasserre, Kaye, Kruesi, Lisa, Del Mar, Christopher and Anuradha, Satyamurthy (2008). Putting Wikipedia to the Test: A Case Study. The Special Libraries Association Annual Conference, Seattle, Washington, USA, June 16, 2008.
Brennan, Rebekah M., Burrows, Jacqueline M., Bell, Melissa J., Lenarczyk, Aleksandra, Csurhes, Peter A., Pender, Michael. and Burrows, Scott R. (2008). Infection with specific strains of Epstein-Barr virus are a risk factor for multiple sclerosis. Joint World Congress on Treatment and Research in Multiple Sclerosis: 13th Annnual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis / 24th Congress of the European Committee for Treatment and Research in Multiple Sclerosis / 5th Congress of the Latin American Committee for Treatment and Research in Multiple Sclerosis, Montréal, QC, Canada, 17-20 September 2008. London, U.K.: Sage Publications. doi: 10.1177/1352458508096399
Greer, Judith M. and Pender, Michael P. (2008). Myelin proteolipid protein: An effective autoantigen and target of autoimmunity in multiple sclerosis. 11th Australasian Autoimmunity Workshop, Melbourne, VIC, Australia, 6 - 8 July 2007. London, United Kingdom: Academic Press. doi: 10.1016/j.jaut.2008.04.018
Greer, Judith, Csurhes, Peter, Muller, Diane and Pender, Michael (2008). Role of autoreactivity against myelin proteolipid protein in multiple sclerosis. ISNI 2008: 9th International Congress of Neuroimmunology, Fort Worth, TX, U.S.A., October 26-30, 2008. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jneuroim.2008.08.001
Pender, M. P., Csurhes, P. A. and Greer, J. M. (2006). T-cell reactivity to myelin proteolipid protein drives the development of brainstem and cerebellar lesions in multiple sclerosis. 8th International Conference on Neuroimmunology, Nagoya, Japan, 15-19 October 2006. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.jneuroim.2006.07.002
Yan, J., Pat, B., Winterford, C., Inglis, F., Pender, M. P. and Greer, J. M. (2005). Increased constitutive activation of NF-kappa B in patients with multiple sclerosis. 5th Annual Meeting of the Federation of Clinical Immunology Society, Boston, MA, United States, 12-16 May 2005. SAN DIEGO: Academic Press.
Yan, J., Pat, B., Winterford, C., Inglis, H. R., Pender, M. P. and Greer, J. M. (2005). Levels of constitutively activated NF-kB are increased and IB levels are decreased in T cells and macrophages from patients with multiple sclerosis. 35th Annual Scientific Meeting of the Australasian Society for Immunology and 14th International HLA & Immunogenetics Workshop, Melbourne, Australia, 29 November - 2 December 2005. Copenhagen, Denmark: Munksgaard. doi: 10.1111/j.1399-0039.2005.00523.x
Greer, J. M. and Pender, M. P. (2004). Spreading of autoreactivity from antigens present in the thyroid gland to the spinal cord or vice versa: an alternative pathogenic mechanism in MS. 7th International Congress of Neuroimmunology, Venice, 28th September - 2nd October, 2004. United Kingdom: Elsevier.
Greer, J. M., Tan, K. M., Wolfe, N. P., Csurhes, P. A. and Pender, M. P. (2004). Clinical and immunological findings in patients with concurrent MS and autoimmune thyroid disease. ACTRIMS 03, San Francisco, 19 October, 2003. United Kingdom: Arnold.
Pender, M. P. and Greer, J. M. (2004). Increased circulating antibodies to an extracellular domain of myelin proteolipid protein in multiple sclerosis. ECTRIMS 04, Vienna, 6-9 October, 2004. London, United Kingdom: Sage Publications.
Muller, D. M., Pender, M. P. and Greer, J. M. (2004). CXCL1, CXCL2 and CXCR2 are highly expressed in an axial rotatory model of experimental autoimmune encephalomyelitis with polymorphonuclear cell infiltration. ECTRIMS 04, Vienna, 6 - 9 Oct, 2004. United Kingdom: Arnold.
Pender, M. P., Csurhes, P. A., Wolfe, N. P., Cameron, K. D., McCombe, P. A., Greer, J. M. and Good, M. F. (2002). Blood T-cell reactivity to gangliosides GM3 and GQ1b is increased in patients with primary progressive multiple sclerosis. 127th Annual Meeting of the American Neurological Association, New York City, NY, USA, October 12-16 2002. NEW YORK: WILEY-LISS.
Yan, J., Rist, M. J., Dodson, M. J., Pender, M. P. and Greer, J. M. (2002). Comparison of regulatory cell populations in patients with multiple sclerosis and controls. Progress in MS Research, Sydney, 9-11 Oct, 2002.
McCombe, P. A., Sullivan, A. A., Alizart, M. A., Csurhes, P. A., Greer, J. M. and Pender, M. P. (2002). T cell responses to gangliosides in patients with inflammatory neuropathy. Xth International Congress on Neuromuscular Diseases, Vancouver, Canada, 07-12 Jul 2002. Amsterda, The Netherlands: Elseiver. doi: 10.1016/S0022-510X(02)80069-7
Yan, J., Inglis, H., Pender, M. P. and Greer, J. M. (2002). Comparison of NF-kB in immune cells of multiple sclerosis patients and controls Society for Cytokines, Inflammation and Leukocytes. 32nd Annual Scientific Meeting of the ASI, Brisbane, Qld, Australia, 8-12 December, 2002.
Pender, M. P. and Greer, J. M. (2000). Increased circulating anti-myelin antibodies in multiple sclerosis. ANN Meeting, xx, xx. Leith Walkedinburgh, Scotland: Churchill Livingstone. doi: 10.1054/jocn.2000.0668
Muller, D., Pender, M. P. and Greer, J. M. (2000). Inflammatory cell populations in rotatory experimental autoimmune encephalomyelitis. Progress in Multiple Sclerosis Research 2000, Melbourne, 22-24 Nov, 2000. Melbourne: Multiple Sclerosis Australia.
Pender, Michael P. (1999). Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. doi: 10.1046/j.1440-1711.1999.00818.x
Pender, M. P., Csurhes, P. A., Greer, J. M., Mowat, P. D., Henderson, R. D., Cameron, K. D., McCombe, P. A. and Good, M. F. (1999). Fluctuations in the frequencies of circulating myelin-reactive T cells in healthy subjects and patients with multiple sclerosis. ECTRIMS/ACTRIMS'99, Basel, Switzerland, 15 - 18 Sept, 1999. Basingstoke, England: Stockton Press.
Gordon, F., Nguyen, K., White, C. A. and Pender, M. P. (1999). Rapid entry and rapid apoptotic elimination of inflammatory cells in the previously inflamed central nervous system (CNS). 29th Annual Conference of the Australian Society for Immunology, Dunedin, New Zealand, 5-8 Dec, 1999. Dunedin, New Zealand: The Aust. Society for Immunology.
Sullivan, A., Csurhes, P. A., Alizart, M., Pender, M. P. and McCombe, P. A. (1999). The role of PMP-22 as an autoantigen in GBS and CIDP. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., 21 - 27 Oct, 1999. Brisbane: Royal Brisbane Hospital.
Muller, D., Greer, J. M. and Pender, M. P. (1999). A detailed neuropathological analysis of a form of experimental autoimmune encephalomyelitis with predominant brainstem and cerebellar involvment. ECTRIMS/ACTRIMS 99, Basel, Switzerland, 15 - 18 Sept, 1999. UK: Stockton Press.
Cameron, K. D., Csurhes, P. A., Good, M. F., Greer, J. M., Henderson, R. D., McCombe, P. A., Mowat, P. D. and Pender, M. P. (1998). The frequency of circulating T cells reactive to PLP184-209 increases prior to MS relapse and development of new MR1 lesions. Fifth International Congress of the International Society of Neuroimmunology, Montreal, QC, Canada, 23-27 August 1998. doi: 10.1016/S0165-5728(98)91636-8
McCombe, P. A., Nickson, I. and Pender, M. P. (1997). Cytokine mRNA expression in lymphocytes from the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. -, -, -. Hoboken, NJ, United States: Wiley-Blackwell. doi: 10.1111/j.1750-3639.1997.tb01051.x
Pender, M. P., White, C. A. and McCombe, P. A. (1996). Decreased expression of the apoptosis inhibitor Bcl-2 in T cells in the central nervous system in experimental autoimmune encephalomyelitis. American Neurological Association Annual Meeting, Miami FL, United States, 13-16 October 1996. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/ana.410400326
Pender, M. P., Greer, J. M., Csurhes, P. A., Cameron, K. D., McCombe, P. A. and Good, M. F. (1996). T-cell reactivity to peptides of proteolipid protein and myelin basic protein in multiple sclerosis. 121st Annual Meeting of the American Neurological Association, Miami, FL, U.S.A., 13-16 October 1996. BOSTON: LITTLE BROWN CO. doi: 10.1002/ana.410400326
Cameron, K., Csurhes, P., Greer, J., McCombe, P. and Pender, M. (1995). Reactivity to myelin proteolipid protein in multiple sclerosis patients. The 9th International Congress of Immunology, San Francisco, California, USA, 23-29 July 1995. San Francisco, California, USA: American Association of Immunologists and the International Union of Immunological Societies.
Tabi, Z., McCombe, P. A. and Pender, M. P. (1993). Flow cytometric analysis of apoptotic T cells isolated from the central nervous system in experimental autoimmune encephalomyelitis. Joint Meeting of the Australasian Society for Immunology and Society for Leukocyte Biology, Sydney, NSW, Australia, 1-5 December 1993. Bethesda, MD, United States: Federation of American Societies for Experimental Biology.
McCombe, P. A., Csurhes, P. A., Houghten, R. A., Good, M. F. and Pender, M. P. (1993). Human T cell responses to myelin basic protein isoforms. International Congress on the Regulation of Leukocyte Production and Immune Function held at the Joint Meeting of the Australasian Society for Immunology and Society for Leukocyte Biology, Sydney, New South Wales, Australia, 1-5 December 1993. Bethesda, MD, United States: Federation of American Societies for Experimental Biology.
McCombe, P. A., Dejersey, J. and Pender, M. P. (1993). Chronic relapsing experimental autoimmune encephalomyelitis: Studies of cells from the spinal cord. Joint Meeting of the Australasian Society for Immunology and Society for Leukocyte Biology, Sydney, NSW, Australia, 1-5 December 1993. Bethesda, MD, United States: Federation of American Societies for Experimental Biology.
Pender, M. P., Nguyen, K. B., Stanley, G. P. and Yoong, G. (1990). Demyelination and Nerve Conduction Abnormalities in Acute and Chronic Experimental Allergic Encephalomyelitis in the Lewis Rat. XIth International Congress of Neuropathology, Kyoto, Japan, 9-11 September, 1990.